- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Oxygenta Pharmaceutical Ltd has announced the closure of its trading window from October 1 until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30. This measure, affecting designated persons and their associates, is in anticipation of a scheduled board meeting to consider and approve these financial results. This prevents insider trading before the public release of earnings, promoting fair market practices for shareholders.